drugset

drugset / Trial / NCT04921722

Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies

NCT04921722 ↗

Phase 4 Unknown 75 enrolled Children's Hospital of Fudan University

RandomizedParallel-groupSingle-blindTreatment

Summary

In this study, we investigate the safety and efficacy of topical sirolimus in the treatment of superficial complicated vascular anomolies.

Timeline

Start: 2021-10-22
Primary completion: 2025-11-01
Completion: 2025-11-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sirolimus	Small molecule	5 ml	Topical

Indications